Skip to main content

Post-IPO Equity Life Science Companies

Explore 105 life science startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
105
Total Funding
$1.7B
Avg Funding
$69.5M
Cities
20

Export 105 Post-IPO Equity Life Science Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Irvine, United States
$125.0M
raised

Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.

Mar 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Kelowna, Canada
$1.6M
raised

MYND Life Sciences is a life sciences company focused on novel psychedelic drug development and pharmaceuticals.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$3.9M
raised

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$1.4M
raised

Psyence Biomedical is a life science biotechnology company that focuses on advancement of psychedelic medicines.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Naarden, The Netherlands
$452.6M
raised

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 105 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Juan, Puerto Rico
$2.4M
raised

Isla Pharmaceuticals is a biotechnology company that develops tropical disease therapies.

Oct 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Fort Lauderdale, United States
$100K
raised

Psycheceutical is a patented delivery technology that provides safe bioavailable psychedelic pharmaceutical medicines.

Jul 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$40.0M
raised

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$16.5M
raised

Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology.

Apr 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$366.9M
raised

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 105 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$100.0M
raised

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$5.1M
raised

GENinCode is a genetic testing business specializing in the risk assessment and prediction of cardiovascular disease.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Watertown, United States
$45.0M
raised

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$143.8M
raised

Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.

Nov 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Redwood City, United States
$200.0M
raised

Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.

Nov 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 105 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
$3.8M
raised

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$75.0M
raised

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$50.0M
raised

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Marlborough, United States
$43.5M
raised

Akoya Biosciences is a spatial biology company offering solutions for high-parameter tissue analysis from biomarker discovery to validation.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bogotá, Colombia
$600K
raised

Khiron is a medical cannabis company that promotes science, medicine, technology, innovation, and efficiency.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 105 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Houston, United States
$8.0M
raised

Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$34.2M
raised

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$12.2M
raised

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$4.0M
raised

Organicell Regenerative Medicine is an exosome therapeutics company with a focus on developing new biologic medicine.

Jul 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Coquitlam, Canada
$3.0M
raised

Entheon is a addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule.

Apr 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 76 to 100 of 105 companies

Ready to Connect with Post-IPO Equity Life Science Startups?

Get verified founder emails, funding details, and company data for 105 post-ipo equity life science companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked